An Innovative Attempt to Treat Ovarian Cancer by Isolating Circulating Tumor Cells in Blood
A new study was announced recently by the Anderson Cancer Center, University of Texas in collaboration with the biotechnology leadership organization’Biocept’ for investigating the ability to isolate circulating tumor cells (CTC’s) in blood.
The study will use Biocept’s “Cell Enrichment and Extraction Technology,” designed to capture rare cells from a larger heterogeneous cell population. The focus of this study is ovarian cancer.